---
$id: https://graph.org.ai/products/commodity/51161556
$type: Product
source: UNSPSC
code: "51161556"
title: "Tomelukast"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tomelukast

**UNSPSC Code**: 51161556
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-asthmatic agent with the molecular formula C16H22N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 59762X5CLS, chemically known as ly-171,883 but generally known as tomelukast, which bears US NIH Compound Identifier 3969. European Medicines Agency schedules Tomelukast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11184MIG. The term TOMELUKAST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). TOMELUKAST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tomelukast under HS 29339990 and SITC 51577. As of Q4 2014, TOMELUKAST remains the US FDA Preferred Term for this commodity. Tomelukast bears US NLM identifiers UMLS ID C2348803 and NCI Concept Code C74135. SMILES: O(CCCCC1N[NH]NN1)C1C(CCC)C(O)C(CC1)C(=O)C.

